Oder Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$316K Sell
898
-121
-12% -$43.1K 0.24% 81
2025
Q4
$333K Hold
1,019
0.24% 79
2025
Q3
$287K Buy
1,019
+151
+17% +$43.8K 0.21% 83
2025
Q2
$242K Sell
868
-37
-4% -$10.5K 0.18% 92
2025
Q1
$282K Hold
905
0.24% 83
2024
Q4
$236K Hold
905
0.2% 86
2024
Q3
$292K Sell
905
-14
-2% -$4.58K 0.25% 82
2024
Q2
$287K Sell
919
-1
-0.1% -$294 0.26% 83
2024
Q1
$262K Hold
920
0.24% 82
2023
Q4
$265K Buy
920
+1
+0.1% +$272 0.26% 81
2023
Q3
$247K Sell
919
-41
-4% -$10.2K 0.27% 79
2023
Q2
$213K Sell
960
-85
-8% -$19.7K 0.23% 84
2023
Q1
$253K Buy
1,045
+20
+2% +$4.91K 0.3% 76
2022
Q4
$269K Sell
1,025
-173
-14% -$46.4K 0.33% 67
2022
Q3
$270K Hold
1,198
0.32% 72
2022
Q2
$291K Buy
+1,198
New +$294K 0.36% 66
2021
Q3
Sell
-2,938
Closed -$716K 82
2021
Q2
$716K Buy
2,938
+15
+0.5% +$3.69K 0.93% 27
2021
Q1
$727K Buy
2,923
+9
+0.3% +$2.15K 0.99% 26
2020
Q4
$667K Buy
+2,914
New +$672K 0.65% 37

Other funds holding AMGN

Oder Investment Management's AMGN Position: Q1 2026 in Review

Oder Investment Management reduced its Amgen (AMGN) stake by 12% in Q1 2026, selling an estimated $43.1K and leaving 898 shares worth $316K. The position accounts for 0.24% of the portfolio, ranked #81.

Oder Investment Management first reported a position in AMGN in Q4 2020 and has held it in 19 quarters since. The position peaked at $727K in Q1 2021. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Oder Investment Management held 898 shares of Amgen worth $316K as of Q1 2026.
  • Oder Investment Management sold 121 Amgen shares in Q1 2026, an estimated $43.1K.
  • Amgen made up 0.24% of Oder Investment Management's portfolio in Q1 2026, its #81 holding.
  • Oder Investment Management first reported a position in Amgen in Q4 2020 and has held it in 19 quarters since.
  • Oder Investment Management's Amgen position peaked at $727K in Q1 2021.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Oder Investment Management's 13F filing for Q1 2026, filed 5 May 2026.